Page last updated: 2024-11-06

trichlorophene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Trichlorophene is a broad-spectrum antimicrobial agent that has been used in various applications, including personal care products, industrial cleaners, and agricultural fungicides. It is synthesized through the chlorination of phenol, and its effectiveness stems from its ability to disrupt bacterial cell membranes. However, concerns regarding its potential endocrine disrupting effects and environmental persistence have led to its gradual phasing out in many applications. Despite this, its antimicrobial properties continue to be investigated for potential applications in areas such as food preservation and wound healing. Research is ongoing to assess its environmental impact and develop safer alternatives.'

trichlorophene: contains 20 carbon atoms; do not confuse with trichlorophene as name for trichloro derivs of 2,2'-methylenebisphenol (contain 13 carbon atoms) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID62616
CHEMBL ID1337691
SCHEMBL ID6115713
MeSH IDM0044702

Synonyms (41)

Synonym
phenol, 4-chloro-2,6-bis(5-chloro-2-hydroxyphenyl)methyl-
nsc-47932
6642-07-5
NSC47932 ,
NCI60_004133
trichlorophene
4-chloro-2,6-bis[(5-chloro-2-hydroxy-phenyl)methyl]phenol
CBDIVE_008392
NCGC00013581
OPREA1_874129
OPREA1_175944
CBCHROMO1_000017
PROBES1_000378
PROBES2_000370
4-chloro-2,6-bis(5-chloro-2-hydroxybenzyl)phenol
STK366923
NCI47932
NCISTRUC1_000996
NCISTRUC2_001058
NCGC00096694-01
tricycline b
AKOS001483142
4-chloro-2,6-bis[(5-chloro-2-hydroxyphenyl)methyl]phenol
CHEMBL1337691
nsc 47932
g 610
2,6-xylenol, 4-chloro-alpha,alpha'-bis(5-chloro-2-hydroxyphenyl)-
4-chloro-alpha,alpha'-bis(5-chloro-2-hydroxyphenyl)-2,6-xylenol
unii-0y146t7l71
phenol, 4-chloro-2,6-bis((5-chloro-2-hydroxyphenyl)methyl)-
einecs 229-658-9
0y146t7l71 ,
2,6-bis(2-hydroxy-5-chlorobenzyl)-4-chlorophenol
4-chloro-2,6-bis((5-chloro-2-hydroxyphenyl)methyl)phenol
CCG-37446
NCGC00013581-02
SCHEMBL6115713
FT-0698776
DTXSID6041505
2,6-di-(2-hydroxy-5-chlorobenzyl)-4-chlorophenol
Q27231235

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"Experiments have established the high efficacy of combinations of the micronized dosage form of trichlorophen, with albendazole or medamine in treating trichocephaliasis (its causative agent being Trichocephalus muris) in DBA/2st mice and that of trichlorophen in combination with azinox or fenasal in outbred albino mice with hymenolepiasis (its causative agent being Hymenolepis nana)."( [Efficacy of the Russian anthelmintic agent trichlorophen].
Astaf'ev, BA; Fedianina, LV; Gitsu, GA; Lebedeva, MN,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)Homo sapiens (human)Potency3.16230.00137.762544.6684AID914; AID915
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency12.58930.28189.721235.4813AID2326
cytochrome P450 2C19 precursorHomo sapiens (human)Potency1.25890.00255.840031.6228AID899
cytochrome P450 2C9 precursorHomo sapiens (human)Potency2.51190.00636.904339.8107AID883
lethal factor (plasmid)Bacillus anthracis str. A2012Potency3.98110.020010.786931.6228AID912
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency2.51190.00638.235039.8107AID883
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (19)

Assay IDTitleYearJournalArticle
AID1120501Protonophore activity in Bacillus subtilis subsp. subtilis str. 168 assessed as induction of rapid equlibration of delta-pH at 30 uM2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID1120506Induction of membrane disruption in mouse C2C12 cells assessed as maximum increase in oxygen consumption rate at 30 uM2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID576737Antimicrobial activity against Staphylococcus aureus FRI 100 by macrodilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Oligochlorophens are potent inhibitors of Bacillus anthracis.
AID1120513Antimicrobial activity against Bacillus subtilis subsp. subtilis str. 168 after 18 hrs by macro-dilution method2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID1120500Induction of membrane associated proteins mislocalization in Bacillus subtilis subsp. subtilis str. 168 assessed as reduction in GFP-MinD protein localization by fluorescence assay2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID576732Antimicrobial activity against Bacillus cereus2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Oligochlorophens are potent inhibitors of Bacillus anthracis.
AID1120509Increase in bacterial membrane permeability in Bacillus subtilis subsp. subtilis str. 168 at 1 times MIC pre-treated for 5 mins and measured 30 mins post dye addition by propidium iodide dye based flow cytometry2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID1120502Protonophore activity in Bacillus subtilis subsp. subtilis str. 168 assessed as induction of rapid equlibration of delta-pH at 1 times MIC2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID576740Antimicrobial activity against Bacillus anthracis Sterne 7702 by macrodilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Oligochlorophens are potent inhibitors of Bacillus anthracis.
AID576739Antimicrobial activity against Enterococcus faecalis 1131 by macrodilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Oligochlorophens are potent inhibitors of Bacillus anthracis.
AID576738Antimicrobial activity against Staphylococcus aureus FRI 361 by macrodilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Oligochlorophens are potent inhibitors of Bacillus anthracis.
AID1120510Induction of transmembrane potential loss in Bacillus subtilis subsp. subtilis str. 168 at 1 times MIC pre-treated for 5 mins and measured 15 mins post dye addition by DiOC2 dye based flow cytometry2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID576736Antimicrobial activity against Caulobacter crescentus CB15N by macrodilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Oligochlorophens are potent inhibitors of Bacillus anthracis.
AID576733Antimicrobial activity against Escherichia coli MC1000 by macrodilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Oligochlorophens are potent inhibitors of Bacillus anthracis.
AID576903Antimicrobial activity against Bacillus anthracis Sterne 7702 selected after 18 passages by macrodilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Oligochlorophens are potent inhibitors of Bacillus anthracis.
AID576735Antimicrobial activity against Bacillus cereus UW85 by macrodilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Oligochlorophens are potent inhibitors of Bacillus anthracis.
AID767362Inhibition of C-terminal YFP-fused Escherichia coli FtsZ cloned in Escherichia coli envA1 assessed as mislocalization of protein in polar region at 4.9 uM after 30 to 60 mins by fluorescence microscopic analysis2013Bioorganic & medicinal chemistry, Sep-15, Volume: 21, Issue:18
Chrysophaentins are competitive inhibitors of FtsZ and inhibit Z-ring formation in live bacteria.
AID576734Antimicrobial activity against Pseudomonas aeruginosa K by macrodilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Oligochlorophens are potent inhibitors of Bacillus anthracis.
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.95

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.95 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.95)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (8.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]